aluates Reports

$ 0.0

Automative

Global Meningococcal Infections Vaccine Market Insights, Forecast to 2030

Published Date: December 2024

Report Code: QYRE-Auto-35R5735

Global and United States Meningococcal Infections Vaccine Market Report Forecast 2022 2028

BUY CHAPTERS

Global Meningococcal Infections Vaccine Market Insights, Forecast to 2030

Code: QYRE-Auto-35R5735

Report

December 2024

Pages:79

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Meningococcal Infections Vaccine Market Size

The global Meningococcal Infections Vaccine market is projected to grow from US$ 513.1 million in 2024 to US$ 679.8 million by 2030, at a Compound Annual Growth Rate (CAGR) of 4.8% during the forecast period.

Meningococcal Infections Vaccine Market

Meningococcal vaccine refers to any of the vaccines used to prevent infection by Neisseria meningitidis.Different versions are effective against some or all of the following types of meningococcus: A, C, W-135,and Y.The vaccines are between 85 and 100% effective for at least two years.They result in a decrease in meningitis and sepsis among populations where they are widely used.They are given either by injection into a muscle or just under the skin.

Market Analysis and Insights: Global Meningococcal Infections Vaccine Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Covers:

This report presents an overview of global market for Meningococcal Infections Vaccine market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Meningococcal Infections Vaccine, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Meningococcal Infections Vaccine, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Meningococcal Infections Vaccine revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Meningococcal Infections Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Meningococcal Infections Vaccine revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Meningococcal Infections Vaccine Market Report

Report Metric	Details
Report Name	Meningococcal Infections Vaccine Market
Accounted market size in 2024	US$ 513.1 million
Forecasted market size in 2030	US$ 679.8 million
CAGR	4.8
Base Year	2024
Forecasted years	2025 - 2030
Segment by Type	Bivalent Quadrivalent
Segment by Application	Group A Meningococcal Bacterial Infections Group C Meningococcal Bacterial Infectio
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Pfizer, Sinopharm, CanSino Biologics, Zhi Fei Biological
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Meningococcal Infections Vaccine in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Meningococcal Infections Vaccine companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Meningococcal Infections Vaccine revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is Meningococcal Infections Vaccine Market growing?

Ans: The Meningococcal Infections Vaccine Market witnessing a CAGR of 4.8 during the forecast period 2025-2030.

What is the Meningococcal Infections Vaccine Market size in 2030?

Ans: The Meningococcal Infections Vaccine Market size in 2030 will be US$ 679.8 million.

Who are the main players in the Meningococcal Infections Vaccine Market report?

Ans: The main players in the Meningococcal Infections Vaccine Market are Pfizer, Sinopharm, CanSino Biologics, Zhi Fei Biological

What are the Application segmentation covered in the Meningococcal Infections Vaccine Market report?

Ans: The Applications covered in the Meningococcal Infections Vaccine Market report are Group A Meningococcal Bacterial Infections, Group C Meningococcal Bacterial Infectio

What are the Type segmentation covered in the Meningococcal Infections Vaccine Market report?

Ans: The Types covered in the Meningococcal Infections Vaccine Market report are Bivalent, Quadrivalent

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Meningococcal Infections Vaccine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Bivalent

1.2.3 Quadrivalent

1.3 Market by Application

1.3.1 Global Meningococcal Infections Vaccine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Group A Meningococcal Bacterial Infections

1.3.3 Group C Meningococcal Bacterial Infectio

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Meningococcal Infections Vaccine Market Perspective (2019-2030)

2.2 Global Meningococcal Infections Vaccine Growth Trends by Region

2.2.1 Meningococcal Infections Vaccine Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Meningococcal Infections Vaccine Historic Market Size by Region (2019-2024)

2.2.3 Meningococcal Infections Vaccine Forecasted Market Size by Region (2025-2030)

2.3 Meningococcal Infections Vaccine Market Dynamics

2.3.1 Meningococcal Infections Vaccine Industry Trends

2.3.2 Meningococcal Infections Vaccine Market Drivers

2.3.3 Meningococcal Infections Vaccine Market Challenges

2.3.4 Meningococcal Infections Vaccine Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Meningococcal Infections Vaccine by Players

3.1.1 Global Meningococcal Infections Vaccine Revenue by Players (2019-2024)

3.1.2 Global Meningococcal Infections Vaccine Revenue Market Share by Players (2019-2024)

3.2 Global Meningococcal Infections Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Meningococcal Infections Vaccine, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Meningococcal Infections Vaccine Market Concentration Ratio

3.4.1 Global Meningococcal Infections Vaccine Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Meningococcal Infections Vaccine Revenue in 2023

3.5 Global Key Players of Meningococcal Infections Vaccine Head office and Area Served

3.6 Global Key Players of Meningococcal Infections Vaccine, Product and Application

3.7 Global Key Players of Meningococcal Infections Vaccine, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Meningococcal Infections Vaccine Breakdown Data by Type

4.1 Global Meningococcal Infections Vaccine Historic Market Size by Type (2019-2024)

4.2 Global Meningococcal Infections Vaccine Forecasted Market Size by Type (2025-2030)

5 Meningococcal Infections Vaccine Breakdown Data by Application

5.1 Global Meningococcal Infections Vaccine Historic Market Size by Application (2019-2024)

5.2 Global Meningococcal Infections Vaccine Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Meningococcal Infections Vaccine Market Size (2019-2030)

6.2 North America Meningococcal Infections Vaccine Market Size by Type

6.2.1 North America Meningococcal Infections Vaccine Market Size by Type (2019-2024)

6.2.2 North America Meningococcal Infections Vaccine Market Size by Type (2025-2030)

6.2.3 North America Meningococcal Infections Vaccine Market Share by Type (2019-2030)

6.3 North America Meningococcal Infections Vaccine Market Size by Application

6.3.1 North America Meningococcal Infections Vaccine Market Size by Application (2019-2024)

6.3.2 North America Meningococcal Infections Vaccine Market Size by Application (2025-2030)

6.3.3 North America Meningococcal Infections Vaccine Market Share by Application (2019-2030)

6.4 North America Meningococcal Infections Vaccine Market Size by Country

6.4.1 North America Meningococcal Infections Vaccine Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Meningococcal Infections Vaccine Market Size by Country (2019-2024)

6.4.3 North America Meningococcal Infections Vaccine Market Size by Country (2025-2030)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Meningococcal Infections Vaccine Market Size (2019-2030)

7.2 Europe Meningococcal Infections Vaccine Market Size by Type

7.2.1 Europe Meningococcal Infections Vaccine Market Size by Type (2019-2024)

7.2.2 Europe Meningococcal Infections Vaccine Market Size by Type (2025-2030)

7.2.3 Europe Meningococcal Infections Vaccine Market Share by Type (2019-2030)

7.3 Europe Meningococcal Infections Vaccine Market Size by Application

7.3.1 Europe Meningococcal Infections Vaccine Market Size by Application (2019-2024)

7.3.2 Europe Meningococcal Infections Vaccine Market Size by Application (2025-2030)

7.3.3 Europe Meningococcal Infections Vaccine Market Share by Application (2019-2030)

7.4 Europe Meningococcal Infections Vaccine Market Size by Country

7.4.1 Europe Meningococcal Infections Vaccine Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Meningococcal Infections Vaccine Market Size by Country (2019-2024)

7.4.3 Europe Meningococcal Infections Vaccine Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Meningococcal Infections Vaccine Market Size (2019-2030)

8.2 China Meningococcal Infections Vaccine Market Size by Type

8.2.1 China Meningococcal Infections Vaccine Market Size by Type (2019-2024)

8.2.2 China Meningococcal Infections Vaccine Market Size by Type (2025-2030)

8.2.3 China Meningococcal Infections Vaccine Market Share by Type (2019-2030)

8.3 China Meningococcal Infections Vaccine Market Size by Application

8.3.1 China Meningococcal Infections Vaccine Market Size by Application (2019-2024)

8.3.2 China Meningococcal Infections Vaccine Market Size by Application (2025-2030)

8.3.3 China Meningococcal Infections Vaccine Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Meningococcal Infections Vaccine Market Size (2019-2030)

9.2 Asia Meningococcal Infections Vaccine Market Size by Type

9.2.1 Asia Meningococcal Infections Vaccine Market Size by Type (2019-2024)

9.2.2 Asia Meningococcal Infections Vaccine Market Size by Type (2025-2030)

9.2.3 Asia Meningococcal Infections Vaccine Market Share by Type (2019-2030)

9.3 Asia Meningococcal Infections Vaccine Market Size by Application

9.3.1 Asia Meningococcal Infections Vaccine Market Size by Application (2019-2024)

9.3.2 Asia Meningococcal Infections Vaccine Market Size by Application (2025-2030)

9.3.3 Asia Meningococcal Infections Vaccine Market Share by Application (2019-2030)

9.4 Asia Meningococcal Infections Vaccine Market Size by Region

9.4.1 Asia Meningococcal Infections Vaccine Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Meningococcal Infections Vaccine Market Size by Region (2019-2024)

9.4.3 Asia Meningococcal Infections Vaccine Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Meningococcal Infections Vaccine Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Meningococcal Infections Vaccine Market Size by Type

10.2.1 Middle East, Africa, and Latin America Meningococcal Infections Vaccine Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Meningococcal Infections Vaccine Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Meningococcal Infections Vaccine Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Meningococcal Infections Vaccine Market Size by Application

10.3.1 Middle East, Africa, and Latin America Meningococcal Infections Vaccine Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Meningococcal Infections Vaccine Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Meningococcal Infections Vaccine Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Meningococcal Infections Vaccine Market Size by Country

10.4.1 Middle East, Africa, and Latin America Meningococcal Infections Vaccine Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Meningococcal Infections Vaccine Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Meningococcal Infections Vaccine Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Pfizer

11.1.1 Pfizer Company Details

11.1.2 Pfizer Business Overview

11.1.3 Pfizer Meningococcal Infections Vaccine Introduction

11.1.4 Pfizer Revenue in Meningococcal Infections Vaccine Business (2019-2024)

11.1.5 Pfizer Recent Developments

11.2 Sinopharm

11.2.1 Sinopharm Company Details

11.2.2 Sinopharm Business Overview

11.2.3 Sinopharm Meningococcal Infections Vaccine Introduction

11.2.4 Sinopharm Revenue in Meningococcal Infections Vaccine Business (2019-2024)

11.2.5 Sinopharm Recent Developments

11.3 CanSino Biologics

11.3.1 CanSino Biologics Company Details

11.3.2 CanSino Biologics Business Overview

11.3.3 CanSino Biologics Meningococcal Infections Vaccine Introduction

11.3.4 CanSino Biologics Revenue in Meningococcal Infections Vaccine Business (2019-2024)

11.3.5 CanSino Biologics Recent Developments

11.4 Zhi Fei Biological

11.4.1 Zhi Fei Biological Company Details

11.4.2 Zhi Fei Biological Business Overview

11.4.3 Zhi Fei Biological Meningococcal Infections Vaccine Introduction

11.4.4 Zhi Fei Biological Revenue in Meningococcal Infections Vaccine Business (2019-2024)

11.4.5 Zhi Fei Biological Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

List of Tables

Table 1. Global Meningococcal Infections Vaccine Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of Bivalent

Table 3. Key Players of Quadrivalent

Table 4. Global Meningococcal Infections Vaccine Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 5. Global Meningococcal Infections Vaccine Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Meningococcal Infections Vaccine Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global Meningococcal Infections Vaccine Market Share by Region (2019-2024)

Table 8. Global Meningococcal Infections Vaccine Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global Meningococcal Infections Vaccine Market Share by Region (2025-2030)

Table 10. Meningococcal Infections Vaccine Market Trends

Table 11. Meningococcal Infections Vaccine Market Drivers

Table 12. Meningococcal Infections Vaccine Market Challenges

Table 13. Meningococcal Infections Vaccine Market Restraints

Table 14. Global Meningococcal Infections Vaccine Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global Meningococcal Infections Vaccine Revenue Share by Players (2019-2024)

Table 16. Global Top Meningococcal Infections Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Meningococcal Infections Vaccine as of 2023)

Table 17. Global Meningococcal Infections Vaccine Industry Ranking 2022 VS 2023 VS 2024

Table 18. Global 5 Largest Players Market Share by Meningococcal Infections Vaccine Revenue (CR5 and HHI) & (2019-2024)

Table 19. Global Key Players of Meningococcal Infections Vaccine, Headquarters and Area Served

Table 20. Global Key Players of Meningococcal Infections Vaccine, Product and Application

Table 21. Global Key Players of Meningococcal Infections Vaccine, Product and Application

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Meningococcal Infections Vaccine Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global Meningococcal Infections Vaccine Revenue Market Share by Type (2019-2024)

Table 25. Global Meningococcal Infections Vaccine Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global Meningococcal Infections Vaccine Revenue Market Share by Type (2025-2030)

Table 27. Global Meningococcal Infections Vaccine Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global Meningococcal Infections Vaccine Revenue Share by Application (2019-2024)

Table 29. Global Meningococcal Infections Vaccine Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global Meningococcal Infections Vaccine Revenue Share by Application (2025-2030)

Table 31. North America Meningococcal Infections Vaccine Market Size by Type (2019-2024) & (US$ Million)

Table 32. North America Meningococcal Infections Vaccine Market Size by Type (2025-2030) & (US$ Million)

Table 33. North America Meningococcal Infections Vaccine Market Size by Application (2019-2024) & (US$ Million)

Table 34. North America Meningococcal Infections Vaccine Market Size by Application (2025-2030) & (US$ Million)

Table 35. North America Meningococcal Infections Vaccine Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. North America Meningococcal Infections Vaccine Market Size by Country (2019-2024) & (US$ Million)

Table 37. North America Meningococcal Infections Vaccine Market Size by Country (2025-2030) & (US$ Million)

Table 38. Europe Meningococcal Infections Vaccine Market Size by Type (2019-2024) & (US$ Million)

Table 39. Europe Meningococcal Infections Vaccine Market Size by Type (2025-2030) & (US$ Million)

Table 40. Europe Meningococcal Infections Vaccine Market Size by Application (2019-2024) & (US$ Million)

Table 41. Europe Meningococcal Infections Vaccine Market Size by Application (2025-2030) & (US$ Million)

Table 42. Europe Meningococcal Infections Vaccine Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 43. Europe Meningococcal Infections Vaccine Market Size by Country (2019-2024) & (US$ Million)

Table 44. Europe Meningococcal Infections Vaccine Market Size by Country (2025-2030) & (US$ Million)

Table 45. China Meningococcal Infections Vaccine Market Size by Type (2019-2024) & (US$ Million)

Table 46. China Meningococcal Infections Vaccine Market Size by Type (2025-2030) & (US$ Million)

Table 47. China Meningococcal Infections Vaccine Market Size by Application (2019-2024) & (US$ Million)

Table 48. China Meningococcal Infections Vaccine Market Size by Application (2025-2030) & (US$ Million)

Table 49. Asia Meningococcal Infections Vaccine Market Size by Type (2019-2024) & (US$ Million)

Table 50. Asia Meningococcal Infections Vaccine Market Size by Type (2025-2030) & (US$ Million)

Table 51. Asia Meningococcal Infections Vaccine Market Size by Application (2019-2024) & (US$ Million)

Table 52. Asia Meningococcal Infections Vaccine Market Size by Application (2025-2030) & (US$ Million)

Table 53. Asia Meningococcal Infections Vaccine Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 54. Asia Meningococcal Infections Vaccine Market Size by Region (2019-2024) & (US$ Million)

Table 55. Asia Meningococcal Infections Vaccine Market Size by Region (2025-2030) & (US$ Million)

Table 56. Middle East, Africa, and Latin America Meningococcal Infections Vaccine Market Size by Type (2019-2024) & (US$ Million)

Table 57. Middle East, Africa, and Latin America Meningococcal Infections Vaccine Market Size by Type (2025-2030) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Meningococcal Infections Vaccine Market Size by Application (2019-2024) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Meningococcal Infections Vaccine Market Size by Application (2025-2030) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Meningococcal Infections Vaccine Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 61. Middle East, Africa, and Latin America Meningococcal Infections Vaccine Market Size by Country (2019-2024) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Meningococcal Infections Vaccine Market Size by Country (2025-2030) & (US$ Million)

Table 63. Pfizer Company Details

Table 64. Pfizer Business Overview

Table 65. Pfizer Meningococcal Infections Vaccine Product

Table 66. Pfizer Revenue in Meningococcal Infections Vaccine Business (2019-2024) & (US$ Million)

Table 67. Pfizer Recent Developments

Table 68. Sinopharm Company Details

Table 69. Sinopharm Business Overview

Table 70. Sinopharm Meningococcal Infections Vaccine Product

Table 71. Sinopharm Revenue in Meningococcal Infections Vaccine Business (2019-2024) & (US$ Million)

Table 72. Sinopharm Recent Developments

Table 73. CanSino Biologics Company Details

Table 74. CanSino Biologics Business Overview

Table 75. CanSino Biologics Meningococcal Infections Vaccine Product

Table 76. CanSino Biologics Revenue in Meningococcal Infections Vaccine Business (2019-2024) & (US$ Million)

Table 77. CanSino Biologics Recent Developments

Table 78. Zhi Fei Biological Company Details

Table 79. Zhi Fei Biological Business Overview

Table 80. Zhi Fei Biological Meningococcal Infections Vaccine Product

Table 81. Zhi Fei Biological Revenue in Meningococcal Infections Vaccine Business (2019-2024) & (US$ Million)

Table 82. Zhi Fei Biological Recent Developments

Table 83. Research Programs/Design for This Report

Table 84. Key Data Information from Secondary Sources

Table 85. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Meningococcal Infections Vaccine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Meningococcal Infections Vaccine Market Share by Type: 2023 VS 2030

Figure 3. Bivalent Features

Figure 4. Quadrivalent Features

Figure 5. Global Meningococcal Infections Vaccine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 6. Global Meningococcal Infections Vaccine Market Share by Application: 2023 VS 2030

Figure 7. Group A Meningococcal Bacterial Infections Case Studies

Figure 8. Group C Meningococcal Bacterial Infectio Case Studies

Figure 9. Meningococcal Infections Vaccine Report Years Considered

Figure 10. Global Meningococcal Infections Vaccine Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 11. Global Meningococcal Infections Vaccine Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 12. Global Meningococcal Infections Vaccine Market Share by Region: 2023 VS 2030

Figure 13. Global Meningococcal Infections Vaccine Market Share by Players in 2023

Figure 14. Global Top Meningococcal Infections Vaccine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Meningococcal Infections Vaccine as of 2023)

Figure 15. The Top 10 and 5 Players Market Share by Meningococcal Infections Vaccine Revenue in 2023

Figure 16. North America Meningococcal Infections Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 17. North America Meningococcal Infections Vaccine Market Share by Type (2019-2030)

Figure 18. North America Meningococcal Infections Vaccine Market Share by Application (2019-2030)

Figure 19. North America Meningococcal Infections Vaccine Market Share by Country (2019-2030)

Figure 20. United States Meningococcal Infections Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Canada Meningococcal Infections Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Europe Meningococcal Infections Vaccine Market Size YoY (2019-2030) & (US$ Million)

Figure 23. Europe Meningococcal Infections Vaccine Market Share by Type (2019-2030)

Figure 24. Europe Meningococcal Infections Vaccine Market Share by Application (2019-2030)

Figure 25. Europe Meningococcal Infections Vaccine Market Share by Country (2019-2030)

Figure 26. Germany Meningococcal Infections Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. France Meningococcal Infections Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. U.K. Meningococcal Infections Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Italy Meningococcal Infections Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Russia Meningococcal Infections Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Nordic Countries Meningococcal Infections Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. China Meningococcal Infections Vaccine Market Size YoY (2019-2030) & (US$ Million)

Figure 33. China Meningococcal Infections Vaccine Market Share by Type (2019-2030)

Figure 34. China Meningococcal Infections Vaccine Market Share by Application (2019-2030)

Figure 35. Asia Meningococcal Infections Vaccine Market Size YoY (2019-2030) & (US$ Million)

Figure 36. Asia Meningococcal Infections Vaccine Market Share by Type (2019-2030)

Figure 37. Asia Meningococcal Infections Vaccine Market Share by Application (2019-2030)

Figure 38. Asia Meningococcal Infections Vaccine Market Share by Region (2019-2030)

Figure 39. Japan Meningococcal Infections Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. South Korea Meningococcal Infections Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. China Taiwan Meningococcal Infections Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Southeast Asia Meningococcal Infections Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. India Meningococcal Infections Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Australia Meningococcal Infections Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Middle East, Africa, and Latin America Meningococcal Infections Vaccine Market Size YoY (2019-2030) & (US$ Million)

Figure 46. Middle East, Africa, and Latin America Meningococcal Infections Vaccine Market Share by Type (2019-2030)

Figure 47. Middle East, Africa, and Latin America Meningococcal Infections Vaccine Market Share by Application (2019-2030)

Figure 48. Middle East, Africa, and Latin America Meningococcal Infections Vaccine Market Share by Country (2019-2030)

Figure 49. Brazil Meningococcal Infections Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 50. Mexico Meningococcal Infections Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 51. Turkey Meningococcal Infections Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 52. Saudi Arabia Meningococcal Infections Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 53. Israel Meningococcal Infections Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. GCC Countries Meningococcal Infections Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. Pfizer Revenue Growth Rate in Meningococcal Infections Vaccine Business (2019-2024)

Figure 56. Sinopharm Revenue Growth Rate in Meningococcal Infections Vaccine Business (2019-2024)

Figure 57. CanSino Biologics Revenue Growth Rate in Meningococcal Infections Vaccine Business (2019-2024)

Figure 58. Zhi Fei Biological Revenue Growth Rate in Meningococcal Infections Vaccine Business (2019-2024)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions